G

Genematrix Inc
KOSDAQ:109820

Watchlist Manager
Genematrix Inc
KOSDAQ:109820
Watchlist
Price: 2 405 KRW Market Closed
Market Cap: 49B KRW

Genematrix Inc
Investor Relations

GENEMATRIX, Inc. engages in the development of platform and molecular diagnostics products. The company is headquartered in Seongnam, Gyeonggi-Do and currently employs 60 full-time employees. The company went IPO on 2009-11-06. The firm operates in two segments: pharmaceutical development and diagnostic medicine. Its pharmaceutical development segment specializes in the development of restriction fragment mass polymorphism (RFMP) genotyping technology for diagnosis of hepatitis B virus (HBV), hepatitis C virus (HCV), human papillomavirus (HPV) and others. Its diagnostic medicine segment specializes in the manufacture and sale of liver-function examination reagents, and import and sale of medical equipment and reagents.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Soook Kim
President & CEO
No Bio Available
Suk-Joon Kim
Senior Managing Director and Executive Director
No Bio Available

Contacts

Address
GYEONGGI-DO
Seongnam
700, Daewangpangyo-ro, Bundang-gu
Contacts